Analysts expect revenue increase Merck & Co

Tomorrow American Merck KGaA & Co will report her results over the past quarter. For this year the consensus of the revenue equals 39,7 billion dollars. This is slightly more than the 2015's revenue of 39,5 billion dollars.

Historical revenues and results Merck KGaA & Co plus taxations 2016

fundamental research

The analysts expect for 2016 a net profit of 10,44 billion dollars. For this year most of the analysts expect a profit per share of 3,75 dollars. Based on the analyst's expectations the price/earnings-ratio is 16,32.

For this year the consensus of the dividend per share equals 1,82 dollars. The dividend return consequently equals 2,97 percent. On average the pharmaceutical company yields a rather high dividend yield of around 2,61 percent.

Latest target prices around 18 dollars

The stock Merck KGaA & Co is being covered by 6 fundamental analysts. The average target price for the stock is at 76,5 dollars. This is around 11 percent more than the current stock price of 61,2 dollars. Goldman Sachs , Deutsche Bank and HSBC recently provided recommendations for the company.

Based on the number of outstanding shares Merck KGaA & Co's market capitalization equals 170,21 billion dollars.

The stock closed last Friday at 61,2 dollars. News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.